{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:35Z","timestamp":1791295655402,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11255-012-0258-1","type":"journal-article","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T09:42:55Z","timestamp":1344937375000},"page":"139-150","source":"Crossref","is-referenced-by-count":141,"title":["An update on uremic toxins"],"prefix":"10.1007","volume":"45","author":[{"given":"N.","family":"Neirynck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Eloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pletinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"key":"258_CR1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","volume":"20","author":"R Vanholder","year":"2005","unstructured":"Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N (2005) Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transpl 20:1048\u20131056","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder R, De Smet R, Glorieux G et al (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934\u20131943","journal-title":"Kidney Int"},{"key":"258_CR3","doi-asserted-by":"crossref","unstructured":"Duranton F, Cohen G, De Smet R et al (2012) Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23:1258\u20131270","DOI":"10.1681\/ASN.2011121175"},{"key":"258_CR4","first-page":"21","volume":"47","author":"WJ Johnson","year":"1972","unstructured":"Johnson WJ, Hagge WW, Wagoner RD, Dinapoli RP, Rosevear JW (1972) Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 47:21\u201329","journal-title":"Mayo Clin Proc"},{"key":"258_CR5","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","volume":"347","author":"G Eknoyan","year":"2002","unstructured":"Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010\u20132019","journal-title":"N Engl J Med"},{"key":"258_CR6","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","volume":"13","author":"R Paniagua","year":"2002","unstructured":"Paniagua R, Amato D, Vonesh E et al (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307\u20131320","journal-title":"J Am Soc Nephrol"},{"key":"258_CR7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199309303291404","volume":"329","author":"WF Owen Jr","year":"1993","unstructured":"Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM (1993) The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001\u20131006","journal-title":"N Engl J Med"},{"key":"258_CR8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM197403282901301","volume":"290","author":"A Lindner","year":"1974","unstructured":"Lindner A, Charra B, Sherrard DJ, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697\u2013701","journal-title":"N Engl J Med"},{"key":"258_CR9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.ajkd.2008.05.011","volume":"52","author":"A Santoro","year":"2008","unstructured":"Santoro A, Mancini E, Bolzani R et al (2008) The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis 52:507\u2013518","journal-title":"Am J Kidney Dis"},{"key":"258_CR10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1681\/ASN.2008060590","volume":"20","author":"F Locatelli","year":"2009","unstructured":"Locatelli F, Martin-Malo A, Hannedouche T et al (2009) Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 20:645\u2013654","journal-title":"J Am Soc Nephrol"},{"key":"258_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI37672","volume":"120","author":"M D\u2019Apolito","year":"2010","unstructured":"D\u2019Apolito M, Du X, Zong H et al (2010) Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 120:203\u2013213","journal-title":"J Clin Invest"},{"key":"258_CR12","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2003.00912.x","volume":"63","author":"R D\u2019Hooge","year":"2003","unstructured":"D\u2019Hooge R, Van de Vijver G, Van Bogaert PP, Marescau B, Vanholder R, De Deyn PP (2003) Involvement of voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins. Kidney Int 63:1764\u20131775","journal-title":"Kidney Int"},{"key":"258_CR13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(92)90138-B","volume":"112","author":"R D\u2019Hooge","year":"1992","unstructured":"D\u2019Hooge R, Pei YQ, Marescau B, De Deyn PP (1992) Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice. J Neurol Sci 112:96\u2013105","journal-title":"J Neurol Sci"},{"key":"258_CR14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000320765","volume":"30","author":"E Schepers","year":"2010","unstructured":"Schepers E, Glorieux G, Dou L et al (2010) Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. Blood Purif 30:277\u2013287","journal-title":"Blood Purif"},{"key":"258_CR15","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1523-1755.2004.00631.x","volume":"65","author":"GL Glorieux","year":"2004","unstructured":"Glorieux GL, Dhondt AW, Jacobs P et al (2004) In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int 65:2184\u20132192","journal-title":"Kidney Int"},{"key":"258_CR16","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.2215\/CJN.01720211","volume":"6","author":"E Schepers","year":"2011","unstructured":"Schepers E, Barreto DV, Liabeuf S et al (2011) Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin J Am Soc Nephrol 6:2374\u20132383","journal-title":"Clin J Am Soc Nephrol"},{"key":"258_CR17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.ki.5002750","volume":"73","author":"S Eloot","year":"2008","unstructured":"Eloot S, Van Biesen W, Dhondt A et al (2008) Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 73:765\u2013770","journal-title":"Kidney Int"},{"key":"258_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/j.ajkd.2007.05.009","volume":"50","author":"S Eloot","year":"2007","unstructured":"Eloot S, Torremans A, De Smet R et al (2007) Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 50:279\u2013288","journal-title":"Am J Kidney Dis"},{"key":"258_CR19","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/ndt\/gfp059","volume":"24","author":"S Eloot","year":"2009","unstructured":"Eloot S, Van Biesen W, Dhondt A et al (2009) Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis. Nephrol Dial Transpl 24:2225\u20132232","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR20","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.bbamem.2007.04.010","volume":"1768","author":"D Zhao","year":"2007","unstructured":"Zhao D, Sonawane ND, Levin MH, Yang B (2007) Comparative transport efficiencies of urea analogues through urea transporter UT-B. Biochim Biophys Acta 1768:1815\u20131821","journal-title":"Biochim Biophys Acta"},{"key":"258_CR21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ki.1983.108","volume":"23","author":"AK Cheung","year":"1983","unstructured":"Cheung AK, Alford MF, Wilson MM, Leypoldt JK, Henderson LW (1983) Urea movement across erythrocyte membrane during artificial kidney treatment. Kidney Int 23:866\u2013869","journal-title":"Kidney Int"},{"key":"258_CR22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0008-6363(99)00162-5","volume":"43","author":"J Leiper","year":"1999","unstructured":"Leiper J, Vallance P (1999) Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 43:542\u2013548","journal-title":"Cardiovasc Res"},{"key":"258_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","volume":"53","author":"A Meinitzer","year":"2007","unstructured":"Meinitzer A, Seelhorst U, Wellnitz B et al (2007) Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 53:273\u2013283","journal-title":"Clin Chem"},{"key":"258_CR24","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","volume":"358","author":"C Zoccali","year":"2001","unstructured":"Zoccali C, Bode-Boger S, Mallamaci F et al (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113\u20132117","journal-title":"Lancet"},{"key":"258_CR25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ASN.0000032548.18973.0F","volume":"13","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Benedetto FA, Maas R et al (2002) Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13:490\u2013496","journal-title":"J Am Soc Nephrol"},{"key":"258_CR26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","volume":"109","author":"JT Kielstein","year":"2004","unstructured":"Kielstein JT, Impraim B, Simmel S et al (2004) Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109:172\u2013177","journal-title":"Circulation"},{"key":"258_CR27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","volume":"339","author":"P Vallance","year":"1992","unstructured":"Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572\u2013575","journal-title":"Lancet"},{"key":"258_CR28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","volume":"17","author":"SM Bode-Boger","year":"2006","unstructured":"Bode-Boger SM, Scalera F, Kielstein JT et al (2006) Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 17:1128\u20131134","journal-title":"J Am Soc Nephrol"},{"key":"258_CR29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/ndt\/gfn670","volume":"24","author":"E Schepers","year":"2009","unstructured":"Schepers E, Glorieux G, Dhondt A, Leybaert L, Vanholder R (2009) Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transpl 24:1429\u20131435","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5414\/CNP62295","volume":"62","author":"JT Kielstein","year":"2004","unstructured":"Kielstein JT, Boger RH, Bode-Boger SM et al (2004) Low dialysance of asymmetric dimethylarginine (ADMA)\u2014in vivo and in vitro evidence of significant protein binding. Clin Nephrol 62:295\u2013300","journal-title":"Clin Nephrol"},{"key":"258_CR31","doi-asserted-by":"crossref","first-page":"2842S","DOI":"10.1093\/jn\/134.10.2842S","volume":"134","author":"RH Boger","year":"2004","unstructured":"Boger RH (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the \u201cl-arginine paradox\u201d and acts as a novel cardiovascular risk factor. J Nutr 134:2842S\u20132847S","journal-title":"J Nutr"},{"key":"258_CR32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.105.537670","volume":"112","author":"M Tanaka","year":"2005","unstructured":"Tanaka M, Sydow K, Gunawan F et al (2005) Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. Circulation 112:1549\u20131556","journal-title":"Circulation"},{"key":"258_CR33","doi-asserted-by":"crossref","first-page":"H1058","DOI":"10.1152\/ajpheart.01103.2007","volume":"294","author":"J Jacobi","year":"2008","unstructured":"Jacobi J, Maas R, Cordasic N et al (2008) Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. Am J Physiol Heart Circ Physiol 294:H1058\u2013H1066","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"258_CR34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","volume":"13","author":"J Leiper","year":"2007","unstructured":"Leiper J, Nandi M, Torondel B et al (2007) Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 13:198\u2013203","journal-title":"Nat Med"},{"key":"258_CR35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.ajkd.2009.12.035","volume":"55","author":"K Koyama","year":"2010","unstructured":"Koyama K, Ito A, Yamamoto J et al (2010) Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis. Am J Kidney Dis 55:1069\u20131078","journal-title":"Am J Kidney Dis"},{"key":"258_CR36","first-page":"146","volume":"21","author":"R Vanholder","year":"2008","unstructured":"Vanholder R, Van Laecke S, Glorieux G (2008) The middle-molecule hypothesis 30\u00a0years after: lost and rediscovered. J Nephrol 21:146\u2013160","journal-title":"J Nephrol"},{"key":"258_CR37","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/CIRCULATIONAHA.106.683722","volume":"116","author":"AM Wilson","year":"2007","unstructured":"Wilson AM, Kimura E, Harada RK et al (2007) Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation 116:1396\u20131403","journal-title":"Circulation"},{"key":"258_CR38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1291\/hypres.28.505","volume":"28","author":"Y Saijo","year":"2005","unstructured":"Saijo Y, Utsugi M, Yoshioka E et al (2005) Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects. Hypertens Res 28:505\u2013511","journal-title":"Hypertens Res"},{"key":"258_CR39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2362.1996.tb02153.x","volume":"26","author":"E Ripoll","year":"1996","unstructured":"Ripoll E, Revilla M, Hernandez ER, Arribas I, Villa LF, Rico H (1996) New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women. Eur J Clin Invest 26:681\u2013685","journal-title":"Eur J Clin Invest"},{"key":"258_CR40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1681\/ASN.2005020132","volume":"17","author":"AK Cheung","year":"2006","unstructured":"Cheung AK, Rocco MV, Yan G et al (2006) Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17:546\u2013555","journal-title":"J Am Soc Nephrol"},{"key":"258_CR41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2215\/CJN.02340607","volume":"3","author":"AK Cheung","year":"2008","unstructured":"Cheung AK, Greene T, Leypoldt JK et al (2008) Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol 3:69\u201377","journal-title":"Clin J Am Soc Nephrol"},{"key":"258_CR42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2009.503","volume":"77","author":"DV Barreto","year":"2010","unstructured":"Barreto DV, Barreto FC, Liabeuf S et al (2010) Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 77:550\u2013556","journal-title":"Kidney Int"},{"key":"258_CR43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1523-1755.1998.00981.x","volume":"54","author":"PL Kimmel","year":"1998","unstructured":"Kimmel PL, Phillips TM, Simmens SJ et al (1998) Immunologic function and survival in hemodialysis patients. Kidney Int 54:236\u2013244","journal-title":"Kidney Int"},{"key":"258_CR44","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser D, Kollerits B, Neyer U et al (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18:2600\u20132608","journal-title":"J Am Soc Nephrol"},{"key":"258_CR45","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","volume":"32","author":"S Seiler","year":"2011","unstructured":"Seiler S, Cremers B, Rebling NM et al (2011) The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J 32:2688\u20132696","journal-title":"Eur Heart J"},{"key":"258_CR46","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM, Januzzi JL, Isakova T et al (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545\u20132552","journal-title":"Circulation"},{"key":"258_CR47","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584\u2013592","journal-title":"N Engl J Med"},{"key":"258_CR48","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393\u20134408","journal-title":"J Clin Invest"},{"key":"258_CR49","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/ajkd.2002.34918","volume":"40","author":"F Maduell","year":"2002","unstructured":"Maduell F, Navarro V, Cruz MC et al (2002) Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis. Am J Kidney Dis 40:582\u2013589","journal-title":"Am J Kidney Dis"},{"key":"258_CR50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ki.1996.441","volume":"50","author":"F Locatelli","year":"1996","unstructured":"Locatelli F, Mastrangelo F, Redaelli B et al (1996) Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 50:1293\u20131302","journal-title":"Kidney Int"},{"key":"258_CR51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ndt\/gfn522","volume":"24","author":"N Meert","year":"2009","unstructured":"Meert N, Eloot S, Waterloos MA et al (2009) Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transpl 24:562\u2013570","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR52","first-page":"352","volume":"22","author":"N Meert","year":"2009","unstructured":"Meert N, Beerenhout C, Schepers E, Glorieux G, Kooman J, Vanholder R (2009) Evolution of protein-bound uraemic solutes during predilution haemofiltration. J Nephrol 22:352\u2013357","journal-title":"J Nephrol"},{"key":"258_CR53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1525-1594.2010.01005.x","volume":"34","author":"N Meert","year":"2010","unstructured":"Meert N, Waterloos MA, Van Landschoot M et al (2010) Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 34:580\u2013585","journal-title":"Artif Organs"},{"key":"258_CR54","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1093\/ndt\/gfq803","volume":"26","author":"N Meert","year":"2011","unstructured":"Meert N, Eloot S, Schepers E et al (2011) Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transpl 26:2624\u20132630","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR55","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1681\/ASN.V11122344","volume":"11","author":"RA Ward","year":"2000","unstructured":"Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W (2000) A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11:2344\u20132350","journal-title":"J Am Soc Nephrol"},{"key":"258_CR56","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1046\/j.1523-1755.1999.00669.x","volume":"56","author":"JK Leypoldt","year":"1999","unstructured":"Leypoldt JK, Cheung AK, Deeter RB (1999) Rebound kinetics of beta2-microglobulin after hemodialysis. Kidney Int 56:1571\u20131577","journal-title":"Kidney Int"},{"key":"258_CR57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/039139880202500511","volume":"25","author":"S Stiller","year":"2002","unstructured":"Stiller S, Xu XQ, Gruner N, Vienken J, Mann H (2002) Validation of a two-pool model for the kinetics of beta2-microglobulin. Int J Artif Organs 25:411\u2013420","journal-title":"Int J Artif Organs"},{"key":"258_CR58","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ki.1991.114","volume":"39","author":"RA Odell","year":"1991","unstructured":"Odell RA, Slowiaczek P, Moran JE, Schindhelm K (1991) Beta 2-microglobulin kinetics in end-stage renal failure. Kidney Int 39:909\u2013919","journal-title":"Kidney Int"},{"key":"258_CR59","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/ndt\/gfq543","volume":"26","author":"C Basile","year":"2011","unstructured":"Basile C, Libutti P, Di Turo AL et al (2011) Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. Nephrol Dial Transpl 26:1296\u20131303","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR60","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/01.ASN.0000096373.13406.94","volume":"14","author":"AK Cheung","year":"2003","unstructured":"Cheung AK, Levin NW, Greene T et al (2003) Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 14:3251\u20133263","journal-title":"J Am Soc Nephrol"},{"key":"258_CR61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ajkd.2005.09.031","volume":"47","author":"JA Delmez","year":"2006","unstructured":"Delmez JA, Yan G, Bailey J et al (2006) Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis 47:131\u2013138","journal-title":"Am J Kidney Dis"},{"key":"258_CR62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.ajkd.2006.11.026","volume":"49","author":"V Krane","year":"2007","unstructured":"Krane V, Krieter DH, Olschewski M et al (2007) Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 49:267\u2013275","journal-title":"Am J Kidney Dis"},{"key":"258_CR63","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/j.ajkd.2004.11.014","volume":"45","author":"P Chauveau","year":"2005","unstructured":"Chauveau P, Nguyen H, Combe C et al (2005) Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 45:565\u2013571","journal-title":"Am J Kidney Dis"},{"key":"258_CR64","first-page":"85","volume":"12","author":"F Locatelli","year":"1999","unstructured":"Locatelli F, Hannedouche T, Jacobson S et al (1999) The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial. J Nephrol 12:85\u201388","journal-title":"J Nephrol"},{"key":"258_CR65","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/ndt\/gfm453","volume":"22","author":"AA Lopes","year":"2007","unstructured":"Lopes AA, Elder SJ, Ginsberg N et al (2007) Lack of appetite in haemodialysis patients\u2013associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol Dial Transpl 22:3538\u20133546","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR66","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1681\/ASN.2010030280","volume":"21","author":"F Locatelli","year":"2010","unstructured":"Locatelli F, Altieri P, Andrulli S et al (2010) Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol 21:1798\u20131807","journal-title":"J Am Soc Nephrol"},{"key":"258_CR67","unstructured":"Ok E, Asci G, Ok ES et al (2011) Comparison of postdilution on-line hemodiafiltration and hemodialysis (Turkish HDF study). In: 48th ERA-EDTA Congress Prague\u2014Abstract LBCT2"},{"key":"258_CR68","doi-asserted-by":"crossref","unstructured":"Grooteman MP, van den Dorpel MA, Bots ML et al (2012) Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23:1087\u20131096","DOI":"10.1681\/ASN.2011121140"},{"key":"258_CR69","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1525-139X.2009.00576.x","volume":"22","author":"N Jourde-Chiche","year":"2009","unstructured":"Jourde-Chiche N, Dou L, Cerini C, Gnat-George F, Vanholder R, Brunet P (2009) Protein-bound toxins\u2014update 2009. Semin Dial 22:334\u2013339","journal-title":"Semin Dial"},{"key":"258_CR70","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ndt\/gfr056","volume":"26","author":"R Vanholder","year":"2011","unstructured":"Vanholder R, Bammens B, de Loor H et al (2011) Warning: the unfortunate end of p-cresol as a uraemic toxin. Nephrol Dial Transpl 26:1464\u20131467","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR71","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1681\/ASN.2005030310","volume":"16","author":"AW Martinez","year":"2005","unstructured":"Martinez AW, Recht NS, Hostetter TH, Meyer TW (2005) Removal of P-cresol sulfate by hemodialysis. J Am Soc Nephrol 16:3430\u20133436","journal-title":"J Am Soc Nephrol"},{"key":"258_CR72","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1373\/clinchem.2005.050781","volume":"51","author":"H Loor de","year":"2005","unstructured":"de Loor H, Bammens B, Evenepoel P, De Preter V, Verbeke K (2005) Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum. Clin Chem 51:1535\u20131538","journal-title":"Clin Chem"},{"key":"258_CR73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ki.1995.64","volume":"47","author":"R Vanholder","year":"1995","unstructured":"Vanholder R, De Smet R, Waterloos MA et al (1995) Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 47:510\u2013517","journal-title":"Kidney Int"},{"key":"258_CR74","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","volume":"22","author":"E Schepers","year":"2007","unstructured":"Schepers E, Meert N, Glorieux G, Goeman J, Van der EJ, Vanholder R (2007) P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transpl 22:592\u2013596","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR75","doi-asserted-by":"crossref","unstructured":"Meert N, Schepers E, Glorieux G et al (2011) Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications. Nephrol Dial Transpl 27:2388\u20132396","DOI":"10.1093\/ndt\/gfr672"},{"key":"258_CR76","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.ajkd.2009.04.022","volume":"54","author":"BK Meijers","year":"2009","unstructured":"Meijers BK, Van KS, Verbeke K et al (2009) The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54:891\u2013901","journal-title":"Am J Kidney Dis"},{"key":"258_CR77","doi-asserted-by":"crossref","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","volume":"7","author":"CY Sun","year":"2012","unstructured":"Sun CY, Chang SC, Wu MS (2012) Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition. PLoS One 7:e34026","journal-title":"PLoS One"},{"key":"258_CR78","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"CY Sun","year":"2012","unstructured":"Sun CY, Chang SC, Wu MS (2012) Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int 81:640\u2013650","journal-title":"Kidney Int"},{"key":"258_CR79","unstructured":"Pletinck A, Glorieux G, Schepers E et al (2012) In vivo effects of the protein-bound uremic toxins p-cresylsulfate, p-cresylglucuronide and indoxylsulfate on the cross-talk between leukocytes and the vessel wall. In: 49th ERA-EDTA congress Paris\u2014Abstract FO035"},{"key":"258_CR80","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1373\/49.3.470","volume":"49","author":"R Smet De","year":"2003","unstructured":"De Smet R, Van Kaer J, Van Vlem B et al (2003) Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 49:470\u2013478","journal-title":"Clin Chem"},{"key":"258_CR81","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1046\/j.1523-1755.2003.00310.x","volume":"64","author":"B Bammens","year":"2003","unstructured":"Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y (2003) Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 64:2238\u20132243","journal-title":"Kidney Int"},{"key":"258_CR82","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ki.2008.31","volume":"73","author":"BK Meijers","year":"2008","unstructured":"Meijers BK, Bammens B, De MB, Verbeke K, Vanrenterghem Y, Evenepoel P (2008) Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73:1174\u20131180","journal-title":"Kidney Int"},{"key":"258_CR83","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2215\/CJN.07971109","volume":"5","author":"BK Meijers","year":"2010","unstructured":"Meijers BK, Claes K, Bammens B et al (2010) p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin J Am Soc Nephrol 5:1182\u20131189","journal-title":"Clin J Am Soc Nephrol"},{"key":"258_CR84","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","volume":"69","author":"B Bammens","year":"2006","unstructured":"Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y (2006) Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69:1081\u20131087","journal-title":"Kidney Int"},{"key":"258_CR85","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","volume":"26","author":"IW Wu","year":"2011","unstructured":"Wu IW, Hsu KH, Lee CC et al (2011) p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transpl 26:938\u2013947","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR86","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.atherosclerosis.2010.03.036","volume":"211","author":"CP Wang","year":"2010","unstructured":"Wang CP, Lu LF, Yu TH et al (2010) Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure. Atherosclerosis 211:579\u2013583","journal-title":"Atherosclerosis"},{"key":"258_CR87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1900\/RDS.2010.7.275","volume":"7","author":"CA Chiu","year":"2010","unstructured":"Chiu CA, Lu LF, Yu TH et al (2010) Increased levels of total P-Cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy. Rev Diabet Stud 7:275\u2013284","journal-title":"Rev Diabet Stud"},{"key":"258_CR88","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","volume":"25","author":"S Liabeuf","year":"2010","unstructured":"Liabeuf S, Barreto DV, Barreto FC et al (2010) Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transpl 25:1183\u20131191","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR89","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ndt\/gfr453","volume":"27","author":"IW Wu","year":"2012","unstructured":"Wu IW, Hsu KH, Hsu HJ et al (2012) Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients\u2013a prospective cohort study. Nephrol Dial Transpl 27:1169\u20131175","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR90","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1523-1755.2003.00906.x","volume":"63","author":"M Motojima","year":"2003","unstructured":"Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T (2003) Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells. Kidney Int 63:1671\u20131680","journal-title":"Kidney Int"},{"key":"258_CR91","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","volume":"71","author":"T Nii-Kono","year":"2007","unstructured":"Nii-Kono T, Iwasaki Y, Uchida M et al (2007) Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int 71:738\u2013743","journal-title":"Kidney Int"},{"key":"258_CR92","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","volume":"4","author":"V Faure","year":"2006","unstructured":"Faure V, Dou L, Sabatier F et al (2006) Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 4:566\u2013573","journal-title":"J Thromb Haemost"},{"key":"258_CR93","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/jcb.23435","volume":"113","author":"YS Peng","year":"2012","unstructured":"Peng YS, Lin YT, Chen Y, Hung KY, Wang SM (2012) Effects of indoxyl sulfate on adherens junctions of endothelial cells and the underlying signaling mechanism. J Cell Biochem 113:1034\u20131043","journal-title":"J Cell Biochem"},{"key":"258_CR94","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","volume":"69","author":"H Yamamoto","year":"2006","unstructured":"Yamamoto H, Tsuruoka S, Ioka T et al (2006) Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 69:1780\u20131785","journal-title":"Kidney Int"},{"key":"258_CR95","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","volume":"31","author":"S Lekawanvijit","year":"2010","unstructured":"Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Wang BH, Krum H (2010) Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Heart J 31:1771\u20131779","journal-title":"Eur Heart J"},{"key":"258_CR96","doi-asserted-by":"crossref","first-page":"38869","DOI":"10.1074\/jbc.M110.166686","volume":"285","author":"S Ito","year":"2010","unstructured":"Ito S, Osaka M, Higuchi Y, Nishijima F, Ishii H, Yoshida M (2010) Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. J Biol Chem 285:38869\u201338875","journal-title":"J Biol Chem"},{"key":"258_CR97","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/ndt\/gfm861","volume":"23","author":"A Adijiang","year":"2008","unstructured":"Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T (2008) Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transpl 23:1892\u20131901","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR98","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3747\/pdi.2009.00092","volume":"30","author":"CT Lee","year":"2010","unstructured":"Lee CT, Kuo CC, Chen YM et al (2010) Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis. Perit Dial Int 30:456\u2013463","journal-title":"Perit Dial Int"},{"key":"258_CR99","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","volume":"4","author":"FC Barreto","year":"2009","unstructured":"Barreto FC, Barreto DV, Liabeuf S et al (2009) Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 4:1551\u20131558","journal-title":"Clin J Am Soc Nephrol"},{"key":"258_CR100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ndt\/15.1.50","volume":"15","author":"G Lesaffer","year":"2000","unstructured":"Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R (2000) Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrol Dial Transpl 15:50\u201357","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR101","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1525-1594.2007.00525.x","volume":"32","author":"BK Meijers","year":"2008","unstructured":"Meijers BK, Weber V, Bammens B et al (2008) Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption. Artif Organs 32:214\u2013219","journal-title":"Artif Organs"},{"key":"258_CR102","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1600-6143.2007.01909.x","volume":"7","author":"BK Meijers","year":"2007","unstructured":"Meijers BK, Verhamme P, Nevens F et al (2007) Major coagulation disturbances during fractionated plasma separation and adsorption. Am J Transpl 7:2195\u20132199","journal-title":"Am J Transpl"},{"key":"258_CR103","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.ki.5001640","volume":"70","author":"P Evenepoel","year":"2006","unstructured":"Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y (2006) Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis. Kidney Int 70:794\u2013799","journal-title":"Kidney Int"},{"key":"258_CR104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2215\/CJN.02570607","volume":"3","author":"NM Pham","year":"2008","unstructured":"Pham NM, Recht NS, Hostetter TH, Meyer TW (2008) Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis. Clin J Am Soc Nephrol 3:85\u201390","journal-title":"Clin J Am Soc Nephrol"},{"key":"258_CR105","doi-asserted-by":"crossref","first-page":"S292","DOI":"10.1046\/j.1523-1755.2001.07820.x","volume":"78","author":"N Lameire","year":"2001","unstructured":"Lameire N, Vanholder R, De Smet R (2001) Uremic toxins and peritoneal dialysis. Kidney Int Suppl 78:S292\u2013S297","journal-title":"Kidney Int Suppl"},{"key":"258_CR106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ncpneph1023","volume":"5","author":"R Vanholder","year":"2009","unstructured":"Vanholder R, Meert N, Van Biesen W et al (2009) Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes? Nat Clin Pract Nephrol 5:130\u2013131","journal-title":"Nat Clin Pract Nephrol"},{"key":"258_CR107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000245639","volume":"29","author":"E Schepers","year":"2010","unstructured":"Schepers E, Glorieux G, Vanholder R (2010) The gut: the forgotten organ in uremia? Blood Purif 29:130\u2013136","journal-title":"Blood Purif"},{"key":"258_CR108","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1046\/j.1523-1755.2003.00314.x","volume":"64","author":"B Bammens","year":"2003","unstructured":"Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P (2003) Evidence for impaired assimilation of protein in chronic renal failure. Kidney Int 64:2196\u20132203","journal-title":"Kidney Int"},{"key":"258_CR109","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1681\/ASN.2010121220","volume":"22","author":"PA Aronov","year":"2011","unstructured":"Aronov PA, Luo FJ, Plummer NS et al (2011) Colonic contribution to uremic solutes. J Am Soc Nephrol 22:1769\u20131776","journal-title":"J Am Soc Nephrol"},{"key":"258_CR110","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/ajcn\/63.5.766","volume":"63","author":"A Birkett","year":"1996","unstructured":"Birkett A, Muir J, Phillips J, Jones G, O\u2019Dea K (1996) Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr 63:766\u2013772","journal-title":"Am J Clin Nutr"},{"key":"258_CR111","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ndt\/gfp414","volume":"25","author":"BK Meijers","year":"2010","unstructured":"Meijers BK, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P (2010) p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transpl 25:219\u2013224","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR112","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/ndt\/gfq624","volume":"26","author":"I Nakabayashi","year":"2011","unstructured":"Nakabayashi I, Nakamura M, Kawakami K et al (2011) Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transpl 26:1094\u20131098","journal-title":"Nephrol Dial Transpl"},{"key":"258_CR113","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/j.ajkd.2005.12.036","volume":"47","author":"G Schulman","year":"2006","unstructured":"Schulman G, Agarwal R, Acharya M, Berl T, Blumenthal S, Kopyt N (2006) A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis 47:565\u2013577","journal-title":"Am J Kidney Dis"},{"key":"258_CR114","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000187446","volume":"65","author":"T Niwa","year":"1993","unstructured":"Niwa T, Ise M, Miyazaki T, Meada K (1993) Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats. Nephron 65:82\u201387","journal-title":"Nephron"},{"key":"258_CR115","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1016\/j.jchromb.2010.09.006","volume":"878","author":"K Kikuchi","year":"2010","unstructured":"Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T (2010) Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography\/tandem mass spectrometry. J Chromatogr, B: Anal Technol Biomed Life Sci 878:2997\u20133002","journal-title":"J Chromatogr, B: Anal Technol Biomed Life Sci"},{"key":"258_CR116","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1046\/j.1523-1755.2002.00318.x","volume":"61","author":"T Deguchi","year":"2002","unstructured":"Deguchi T, Ohtsuki S, Otagiri M et al (2002) Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int 61:1760\u20131768","journal-title":"Kidney Int"},{"key":"258_CR117","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/01.ASN.0000022017.96399.B2","volume":"13","author":"A Enomoto","year":"2002","unstructured":"Enomoto A, Takeda M, Tojo A et al (2002) Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 13:1711\u20131720","journal-title":"J Am Soc Nephrol"},{"key":"258_CR118","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1681\/ASN.2009070696","volume":"20","author":"T Toyohara","year":"2009","unstructured":"Toyohara T, Suzuki T, Morimoto R et al (2009) SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol 20:2546\u20132555","journal-title":"J Am Soc Nephrol"},{"key":"258_CR119","doi-asserted-by":"crossref","first-page":"e18438","DOI":"10.1371\/journal.pone.0018438","volume":"6","author":"HA Mutsaers","year":"2011","unstructured":"Mutsaers HA, van den Heuvel LP, Ringens LH et al (2011) Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations. PLoS One 6:e18438","journal-title":"PLoS One"},{"key":"258_CR120","first-page":"96","volume":"124","author":"T Niwa","year":"1994","unstructured":"Niwa T, Ise M (1994) Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 124:96\u2013104","journal-title":"J Lab Clin Med"},{"key":"258_CR121","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000168716","volume":"14","author":"T Niwa","year":"1994","unstructured":"Niwa T, Ise M, Miyazaki T (1994) Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol 14:207\u2013212","journal-title":"Am J Nephrol"},{"key":"258_CR122","first-page":"179","volume":"23","author":"T Niwa","year":"1997","unstructured":"Niwa T, Tsukushi S, Ise M et al (1997) Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Miner Electrolyte Metab 23:179\u2013184","journal-title":"Miner Electrolyte Metab"},{"key":"258_CR123","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ki.1991.233","volume":"40","author":"M Motojima","year":"1991","unstructured":"Motojima M, Nishijima F, Ikoma M et al (1991) Role for \u201curemic toxin\u201d in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 40:461\u2013469","journal-title":"Kidney Int"},{"key":"258_CR124","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1744-9987.2007.00430.x","volume":"11","author":"H Ueda","year":"2007","unstructured":"Ueda H, Shibahara N, Takagi S, Inoue T, Katsuoka Y (2007) AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases. Ther Apher Dial 11:189\u2013195","journal-title":"Ther Apher Dial"},{"key":"258_CR125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","volume":"54","author":"T Akizawa","year":"2009","unstructured":"Akizawa T, Asano Y, Morita S et al (2009) Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. Am J Kidney Dis 54:459\u2013467","journal-title":"Am J Kidney Dis"},{"key":"258_CR126","doi-asserted-by":"crossref","first-page":"c99","DOI":"10.1159\/000097985","volume":"105","author":"T Shoji","year":"2007","unstructured":"Shoji T, Wada A, Inoue K et al (2007) Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function. Nephron Clin Pract 105:c99\u2013c107","journal-title":"Nephron Clin Pract"},{"key":"258_CR127","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.diabres.2008.04.024","volume":"81","author":"K Konishi","year":"2008","unstructured":"Konishi K, Nakano S, Tsuda S, Nakagawa A, Kigoshi T, Koya D (2008) AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects. Diabetes Res Clin Pract 81:310\u2013315","journal-title":"Diabetes Res Clin Pract"},{"key":"258_CR128","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/08860220802356531","volume":"30","author":"H Ueda","year":"2008","unstructured":"Ueda H, Shibahara N, Takagi S, Inoue T, Katsuoka Y (2008) AST-120 treatment in pre-dialysis period affects the prognosis in patients on hemodialysis. Ren Fail 30:856\u2013860","journal-title":"Ren Fail"},{"key":"258_CR129","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2215\/CJN.09981110","volume":"6","author":"S Eloot","year":"2011","unstructured":"Eloot S, Schepers E, Barreto DV et al (2011) Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins. Clin J Am Soc Nephrol 6:1266\u20131273","journal-title":"Clin J Am Soc Nephrol"},{"key":"258_CR130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1525-139X.2011.01003.x","volume":"25","author":"R Vanholder","year":"2012","unstructured":"Vanholder R, Eloot S, Schepers E, Neirynck N, Glorieux G, Massy Z (2012) An Obituary for GFR as the main marker for kidney function? Semin Dial 25:9\u201314","journal-title":"Semin Dial"},{"key":"258_CR131","unstructured":"Neirynck N, Eloot S, Glorieux G et al (2012) Estimated glomerular filtration rate does not associate with the concentration of low molecular weight proteins in chronic kidney disease. In: 49th ERA-EDTA congress, Paris\u2014Abstract SAP192"},{"key":"258_CR132","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa1000552","volume":"363","author":"BA Cooper","year":"2010","unstructured":"Cooper BA, Branley P, Bulfone L et al (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609\u2013619","journal-title":"N Engl J Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-012-0258-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-012-0258-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-012-0258-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T14:30:19Z","timestamp":1643207419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-012-0258-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1007\/s11255-012-0258-1","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,15]]}}}